A phase IIa placebo-controlled, double-blind trial to determine the safety, tolerability, PK/PD of an oral interferon inducer, resiquimod, in chronic HCV
- 30 April 2003
- journal article
- abstracts
- Published by Elsevier in Gastroenterology
- Vol. 124 (4) , A766
- https://doi.org/10.1016/s0016-5085(03)83870-2
Abstract
No abstract availableThis publication has 0 references indexed in Scilit: